Dee Glaser is a Dermatology physician affiliated with Saint Louis University. OpenAlex indexes 163 publications with 3,783 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2315 Dougherty Ferry Rd Ste 200
Saint Louis, MO 631223383
Telephone
314-977-9666Provider last certified this registry record 11 Mar 2021.
Clinical trials
- Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis
Sponsor: St. Louis University
- Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis
Sponsor: Miramar Labs
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20253 payments
- REVANCE THERAPEUTICS, INC.Program year20258 payments
- Ortho Dermatologics, a division of Bausch Health US, LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Porphyrin Precursor100%Aminolevulinic acid hcl100%Part B, office-administered≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of laser shock peening on the mechanisms of fatigue short crack initiation and propagation of AA7075-T651
International Journal of Fatigue
2020 - A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
American Journal of Clinical Dermatology
2019 - Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials
Journal of the American Academy of Dermatology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Ravi Vij
Saint Louis University
Robert Belshe, MD
Saint Louis University
Geoffrey L. Uy
Saint Louis University
Mark Dykewicz, MD
Saint Louis University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”